Orbital Lipomatosis: A Complication of Steroid Therapy in the Sweet Syndrome

Ophthalmic Plast Reconstr Surg. 2016 May-Jun;32(3):e65-7. doi: 10.1097/IOP.0000000000000247.

Abstract

The description of a Sweet syndrome steroid dependant-induced orbital lipomatosis is reported. A 76-year-old-man with history of Sweet syndrome presented with severe bilateral proptosis (Hertel value, 25 mm) with decreased visual acuity and evoked potentials lengthened. A bilateral transpalpebral orbital decompression was performed by resection of intraorbital fat without bone removal. The surgery was uneventful. The volume of resected orbital fat was 15 ml for both sides. Proptosis reduction was 6 mm. Postoperative Hertel values were 19 mm, and evoked potentials were improved. The proptosis was managed successfully. Orbital lipectomy led to minimal sequelae and may be repeated if necessary in this case.

Publication types

  • Case Reports

MeSH terms

  • Adipose Tissue / pathology*
  • Aged
  • Diagnosis, Differential
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Lipomatosis / chemically induced*
  • Lipomatosis / diagnosis
  • Magnetic Resonance Imaging
  • Male
  • Orbit / diagnostic imaging*
  • Orbital Diseases / chemically induced*
  • Orbital Diseases / diagnosis
  • Sweet Syndrome / drug therapy*
  • Tomography, X-Ray Computed

Substances

  • Glucocorticoids